Change search
ReferencesLink to record
Permanent link

Direct link
Risk factor profile and use of cardiovascular drugprevention in women and men with peripheral artery disease
Umeå University, Faculty of Medicine, Department of Public Health and Clinical Medicine, Family Medicine.
Show others and affiliations
2009 (English)In: European Journal of Cardiovascular Prevention & Rehabilitation, ISSN 1741-8267, E-ISSN 1741-8275, Vol. 16, no 1, 39-46 p.Article in journal (Refereed) Published
Abstract [en]

Objective To determine cardiovascular comorbidities and use of cardiovascular disease preventive drugs in patients with peripheral arterial disease (PAD), with special attention to sex differences.

Design A cross-sectional point-prevalence study.

Patients A population sample of patients that are 60-90 years old.

Setting Primary care areas in four Swedish regions.

Main outcome measures Prevalence of PAD stages, comorbidities and medication use.

Results The prevalence of any type of PAD was 18.0% (range 16-20), of asymptomatic peripheral arterial disease (APAD) was 11.1% (range 9-13), intermittent claudication was 6.8% (range 6.5-7.1), and of critical limb ischemia (CLI) was 1.2% (range 1.0-1.5). APAD and CLI were more common in women. Statins were used by 17.5% (range 16.9-18.2), 29.4% (range 29.0-30.1), and 30.3% (range 29.9-30.8) of the patients with APAD, intermittent claudication, and CLI, respectively, and antiplatelet therapy was reported by 34.1% (range 33.7-34.3), 47.6% (range 47.3-47.9), and 60.2% (range 59.1-60.7). The odds ratio for having APAD was 1.7 (range 1.2-2.4) for women with a smoking history of 10 years in relation to nonsmokers. This association was observed only in men who had smoked for at least 30 years or more. Preventive drug use was more common in men with PAD. Compared with women they had an odds ratio of 1.3 (range 1.1-1.5) for lipid-lowering therapy, 1.3 (range 1.0-1.7) for β-blockers or angiotensin-converting enzyme inhibitors, and 1.5 (range 1.2-1.9) for antiplatelet therapy.

Conclusion The patients' risk factor profiles differed among the PAD stages. Smoking duration already seemed to be a risk factor for women with PAD after 10 years of smoking, as compared with 30 years for men, and fewer women reported use of preventive medication. These observations may partly explain the sex differences in prevalence that were observed.

Place, publisher, year, edition, pages
2009. Vol. 16, no 1, 39-46 p.
Keyword [en]
ankle-brachial index, peripheral arterial disease, primary drug prevention, risk factors, sex differences
URN: urn:nbn:se:umu:diva-42377DOI: 10.1097/HJR.0b013e32831c1383OAI: diva2:409154
Available from: 2011-04-07 Created: 2011-04-07 Last updated: 2011-04-07Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Rolandsson, Olov
By organisation
Family Medicine
In the same journal
European Journal of Cardiovascular Prevention & Rehabilitation

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 24 hits
ReferencesLink to record
Permanent link

Direct link